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Rosuvastatin prevents 
cardiovascular events in people 
with elevated C-reactive protein
Increased levels of the inflammatory biomarker high-sensitivity 
C-reactive protein predict cardiovascular events. Since statins 
lower levels of high-sensitivity C-reactive protein as well as 
cholesterol, the authors of a new study hypothesized that peo-
ple with elevated high-sensitivity C-reactive protein levels 
without hyperlipidemia might benefit from statin treatment.
Ridker et al. randomly assigned 17,802 apparently healthy 
men and women with low-density lipoprotein (LDL) choles-
terol levels of less than 130 mg/dl (3.4 mmol/l) and high-
sensitivity C-reactive protein levels of 2.0 mg/l or higher to 
20 mg daily of rosuvastatin, or placebo, and followed them 
for a number of years. The combined primary end point was 
defined as myocardial infarction, stroke, arterial revascular-
ization, hospitalization for unstable angina, or death from 
cardiovascular causes. The trial was stopped after a median 
follow-up of 1.9 years (maximum, 5.0). Rosuvastatin reduced 
LDL cholesterol levels by 50% and high-sensitivity C-reactive 
protein levels by 37%. The rates of the primary end point 
were 0.77 and 1.36 per 100 person-years of follow-up in the 
rosuvastatin and placebo groups, respectively (P < 0.00001). 
Consistent effects were observed in all subgroups evaluated. 
The rosuvastatin group did not have a significant increase 
in myopathy or cancer but did have a higher incidence of 
physician-reported diabetes. The authors conclude that in this 
trial of apparently healthy persons without hyperlipidemia 
but with elevated high-sensitivity C-reactive protein levels, 
rosuvastatin significantly reduced the incidence of major 
cardio vascular events. (N Engl J Med 2008; 359: 2195–2207)
Marc De Broe
Misorientation of the mitotic 
spindle and cystic kidney disease
Primary cilia project from the surface of most vertebrate cells 
and are thought to be sensory organelles. Defects in the cilia 
of the epithelial cells lining kidney tubules underlie nearly 
all types of human cystic kidney diseases. It is currently 
believed that increased proliferation of mutant epithelial 
cells, along with defects in planar cell polarity, plays a role 
in the development of cystic kidney diseases. However, the 
function of the primary cilia in controlling kidney architec-
ture and preventing cyst formation is not understood. Cilia 
and flagella are assembled and maintained by intraflagellar 
transport (IFT). During IFT, large protein complexes called 
IFT particles are transported along the ciliary microtubules 
under the ciliary membrane and carry precursors from the 
site of synthesis in the cell body to the site of ciliary assembly. 
The particles comprise approximately 20 unique subunits 
organized into A and B complexes. In a recent report, Jonas-
sen et al. characterized the function of IFT20, a complex B 
subunit, by generating a floxed allele of Ift20 and deleting 
this gene specifically in kidney collecting duct epithelium. 
Deletion of the gene prevented cilia formation and resulted in 
rapid postnatal cystic expansion of the kidney. Of great inter-
est is their finding that dividing collecting duct cells in early 
stages of cyst formation failed to properly orient their mitotic 
spindles along the tubule (Figure), whereas non-dividing cells 
improperly positioned their centrosomes. Mitotic spindle 
orientation is thought to be controlled by the non-canonical 
branch of the Wnt pathway, but the authors found that at 
later stages, cells lacking cilia had increased canonical Wnt 
signaling and increased rates of proliferation. While cilia can 
function as chemoreceptors and as mechanosensors, several 
other studies suggest that these functions are not involved in 
cytogenesis. Hence, the current study suggests that the cilia 
provide spatial information to control Wnt signaling. It also 
shows that IFT20 couples extracellular events to cell prolif-
eration and differentiation. (J Cell Biol 2008; 183: 377–384; 
doi:10.1083/jcb.200808137)
Juan Oliver
Pericytes and perivascular 
fibroblasts are a source of 
collagen-producing cells  
in obstructive kidney fibrosis
Understanding the origin of scar-producing myofibroblasts is 
a vital component in understanding the mechanisms by which 
fibrosis develops in response to inflammatory injury. Lin et al. 
used a transgenic reporter mouse model expressing enhanced 
green fluorescent protein (GFP) under the regulation of the 
collagen type I, α1 (coll1a1) promoter and enhancers to 
Deletion of Ift20 leads to mitotic spindle misorientation in collecting duct 
cells. In normal kidney tubules, mitotic spindles (phospho-histone H3, 
red) typically orient their axes (white lines) parallel to the long axis of the 
collecting duct (Dolichos biflorus agglutinin, green).
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examine the origins of coll1a1-producing cells in the kid-
ney (Figure). The authors showed that in the normal kidney, 
both podocytes and pericytes generated coll1a1 transcripts, 
as detected by enhanced GFP, and that in the fibrotic kidney, 
coll1a1-GFP expression accurately identified myofibroblasts. 
To determine the direct contribution of circulating immune 
cells to scar production, wild-type mice, chimeric with bone 
marrow from coll-GFP mice, underwent ureteral obstruction 
to induce fibrosis. Histological examination of kidneys from 
these mice showed recruitment of small numbers of fibrocytes 
to the fibrotic kidney, but these fibrocytes made no signifi-
cant contribution to interstitial fibrosis. Instead, using kinetic 
modeling and time-course microscopy, the authors identi-
fied coll1a1-GFP-expressing pericytes as the major source of 
interstitial myofibroblasts in the fibrotic kidney. These studies 
suggest that either vascular injury or vascular factors are the 
most likely triggers for pericyte migration and differentia-
tion into myofibroblasts. Therefore, the authors propose that 
fibrosis research should perhaps be refocused to injury of the 
vasculature rather than injury of the epithelium. (Am J Pathol 
2008; 173: 1617–1627; doi:10.2353/ajpath.2008.080) 
Marc De Broe
Essential role of Klotho  
for FGF23 action
Fibroblast growth factor-23 (FGF23) induces urinary excre-
tion of phosphorus by decreasing its reabsorption in renal 
proximal tubules. Concurrently, FGF23 reduces circulating 
1,25(OH)2D by both decreasing its biosynthesis and increas-
ing its metabolism. Recent studies have shown that to bind 
and signal through its receptor, FGF23 requires Klotho (KL) 
as a cofactor. Klotho and FGF receptor-1(IIIc) form a het-
erodimeric, high-affinity receptor for FGF23. The Klotho 
gene encodes a single-pass transmembrane protein, that is 
expressed in limited tissues, notably in kidney tubules and 
parathyroid. Klotho likely has additional functions, since the 
extracellular domain of the Klotho protein is shed from the 
cell surface. This soluble Klotho appears to regulate multiple 
growth factor signaling pathways. Mice severely hypomorphic 
for Klotho (Kl–/–) display a variety of skeletal and biochemical 
abnormalities similar to those seen in mice with deletion of 
Fgf23. Furthermore, circulating levels of FGF23 are elevated in 
Kl–/– mice, suggesting that resistance to FGF23 action occurs 
in this animal. In addition, many in vitro studies suggest a 
functional cross-talk between Klotho and FGF23. To examine 
the role of Klotho in FGF23 action on mineral and skeletal 
homeostasis in vivo, Bai et al. used a genetic approach. They 
crossed transgenic mice (FTr) expressing a mutant form of 
human FGF23 (R176Q), which is resistant to protease degra-
dation, and Kl–/– mice to introduce the FGF23 (R176Q) trans-
gene onto the Kl–/– genetic background. They found that the 
biochemical abnormalities (hypophosphatemia, phosphaturia, 
abnormal 1,25(OH)2D3 metabolism) and skeletal abnormali-
ties (rickets and osteomalacia) attributable to FGF23 action 
were abrogated in the FTr/Kl–/– mice, which had features simi-
lar to those of the Kl–/– mice. Importantly, whereas in the mice 
with excess human FGF23, renal expression of Cyp27b1 was 
decreased and that of Cyp24 was increased (Figure), resulting 
in decreased serum levels of 1,25(OH)2D3, in FTr/Kl–/– mice, 
increased Cyp27b1 expression was associated with raised cir-
culating levels of the hormone, implying increased protein 
expression and/or enzymatic activity of the elevated Cyp27b1. 
Thus, the lack of Klotho protein in FTr/Kl–/– mice appears 
to prevent FGF23 inhibition of Cyp27b1 renal hydroxylase 
enzymatic activity. Moreover, the increase in Cyp24 may have 
occurred in response to elevated 1,25(OH)2D3 and likely 
prevented the serum concentrations of 1,25(OH)2D3 from 
being more elevated. These findings substantiate the essential 
role of Klotho in the mechanism of action of FGF23 in vivo. 
(Am J Physiol Endocrinol Metab advance online publication, 
4 November 2008, doi:10.1152/ajpendo.90539.2008)
Juan Oliver
Image of the normal glomerulus of a coll-GFP mouse colabeled with 
antibodies against podocin (red), and nuclei labeled with 4,6-diamidino-
2-phenylindole (DAPI; blue). The right panel shows red and blue channels 
only. Podocytes exclusively express GFP in the glomerulus and colocalize 
with podocin.
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1.20 4.50 4.03 4.00
0.14 1.117 0.50 1.22
Northern blot analysis of renal hydroxylase expression. (a) Cyp27b1 and 
(b) Cyp24 expression levels in kidneys from wild-type (WT), Kl–/–, FTr, 
and Kl–/–/FTr mice. Gapdh expression was used as loading control.
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